Compare Organon Pharma Indonesia Tbk. (SCPI) vs Waskita Karya (Persero) Tbk. (WSKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Waskita Karya (Persero) Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Waskita Karya (Persero) Tbk. trades at Rp202 (market cap 5.82T). The key difference: Waskita Karya (Persero) Tbk. is far larger — about 55.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WSKT | |
|---|---|---|
Market Cap | 104.4B | 5.82T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Waskita Karya (Persero) Tbk.
The State Owned Company Waskita Karya (the Company) was established on January 1, 1961 based on Government Regulation No. 62 year 1961, from a foreign company named Volker Aanemings Maatschappij NV which nationalized by the Government of Republic Indonesia. According to Government Regulation No. 40 year 1970, the Companys status was changed from Perusahaan Negara (PN) into Perusahaan (Persero).
Read more on WSKT →
